Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The new ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

Marvel Phase 6 is running full steam ahead, and it's shaping up to be a seismic chapter in the MCU's ongoing tale. With two new Avengers movies, another Spider-Man film, and multiple TV shows in the ...

The 36 teams have discovered their fate for the UEFA Europa League league phase.